Computer-aided detection software developer CureMetrix announced its cmTriage software will be available on the Nuance AI Marketplace.
The CureMetrix software has been cleared by the U.S. Food and Drug Administration (FDA) and is geared toward triaging, sorting, and prioritizing mammography worklists based on cases that may need immediate attention. Studies have demonstrated up to 30% faster reading time for radiologists using cmTriage, according to CureMetrix.
The firm is also conducting investigational studies on its cmAssist software to help identify, mark, and score anomalies in breast cancer screening.
